TXNIP and neoplasm: These findings demonstrate that overexpression of NCL inhibits CD8+ T cell glucose metabolism in vivo by alleviating MYC-mediated transcriptional repression of TXNIP, thereby weakening their infiltration capability in the tumor microenvironment and anti-tumor immunity, ultimately promoting tumor growth.